A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
Clinical trial NCT06422624 · UNKNOWN
Trial details
- NCT number
- NCT06422624
- Sponsor
- Bostal Drug Delivery Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2024-11-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.